The link between osteoarthritis and longevity intrigues patients and researchers alike: does this chronic joint disease, which affects about 10 million people in France, actually raise the risk of premature death? An Italian team first asked the question in 2016 in a meta-analysis covering more than 28,000 people, followed in 2018 by an American cohort of nearly 52,000 adults. Their results converge: osteoarthritis itself does not systematically shorten life, but some of its forms and indirect consequences weigh on healthy life expectancy.
In brief – Osteoarthritis is a chronic, degenerative joint disease that does not directly raise the risk of death, but it does influence longevity through well identified indirect mechanisms. A meta-analysis of 28,559 participants found no increase in all-cause mortality risk once hand osteoarthritis was excluded from the analysis (HR 1.18, 95% CI 1.08 to 1.28), while an American cohort of 51,938 adults found a 1.43-fold higher risk of cardiovascular death and a 2.04-fold higher risk of diabetes-related death in people with radiographic knee osteoarthritis. The link between osteoarthritis and longevity runs mainly through the inactivity it imposes, the chronic low-grade inflammation it sustains, and the cardiometabolic comorbidities that often accompany it, more than through the joint disease itself.
What is osteoarthritis?
Osteoarthritis is a chronic joint disease marked by progressive breakdown of cartilage, together with local inflammation and bone remodeling (osteophytes, sometimes called bone spurs). It mainly affects the knees, hips, hands and spine, and its prevalence rises sharply after age 50: it affects about 65% of people over 65 and up to 80% of people over 80, according to the National Institute on Aging.
Long seen as simple mechanical wear of the cartilage, osteoarthritis is now described as both a degenerative and an inflammatory syndrome, linked to several risk factors: age, excess weight, previous joint injuries and genetics. This updated biological picture partly explains why osteoarthritis and longevity are now studied together: a chronic, localized inflammatory disease can have effects that reach beyond the joint itself.
Mechanisms: three links between osteoarthritis and longevity
Three mechanisms connect osteoarthritis to a higher mortality risk, independent of joint pain itself.
- Forced inactivity: pain and stiffness limit daily physical activity, one of the best documented factors for longevity and cardiovascular health.
- Chronic low-grade inflammation: damaged cartilage releases cytokines and prostaglandins that sustain a systemic inflammatory state, close to the inflammaging process described by Franceschi and Campisi, which is linked to accelerated aging across several organs (Franceschi & Campisi, 2014).
- Cardiometabolic comorbidities: obesity, type 2 diabetes and cardiovascular disease are statistically more common in people with osteoarthritis, partly because of inactivity and partly through metabolic pathways shared by obesity and cartilage breakdown.
These three pathways do not act in isolation: they reinforce one another, which is why the impact of osteoarthritis on longevity varies widely depending on the joint involved and the comorbidities present.
What the science says: osteoarthritis and longevity
The reference study remains the meta-analysis by Veronese and colleagues, published in Seminars in Arthritis and Rheumatism. Covering seven cohorts and 28,559 participants followed for an average of 12 years, it found no all-cause excess mortality among people with osteoarthritis overall (HR 1.10, 95% CI 0.97 to 1.25). But once hand osteoarthritis was excluded from the analysis, the risk became significant (HR 1.18, 95% CI 1.08 to 1.28), as did the risk of cardiovascular death (HR 1.21, 95% CI 1.10 to 1.34) (Veronese et al., 2016).
An American cohort of 51,938 adults, including 2,589 with knee X-rays, refines this picture: self-reported osteoarthritis was not linked to excess mortality, but radiographic knee osteoarthritis was, with a 1.43-fold higher risk of cardiovascular death (95% CI 1.32 to 1.64) and a 2.04-fold higher risk of diabetes-related death (95% CI 1.87 to 2.23). Early-onset radiographic osteoarthritis, appearing before age 40, was associated with a 1.53-fold higher risk of all-cause mortality (Mendy et al., 2018).
For Dr. Belghiti, these figures call for a different way of thinking about osteoarthritis: “The message is not that osteoarthritis kills, but that it often signals a fragile cardiometabolic profile that deserves active monitoring.” This view lines up with the data on physical activity: a meta-analysis of 15 international cohorts shows that a higher daily step count progressively lowers all-cause mortality risk, even in people with limited mobility (Paluch et al., 2022).
These results remain statistical associations observed at large scale, not proof of individual causation. Knee osteoarthritis does not predict a personal outcome; it signals a higher probability of cardiometabolic complications that deserves medical follow-up, not fatalism.
In practice: who should monitor the link between osteoarthritis and longevity
Vigilance matters most for radiographic osteoarthritis of the knee or hip, especially when it comes with excess weight, diabetes or a marked limitation in mobility. Isolated hand osteoarthritis, by contrast, has shown no impact on survival in the available cohorts and does not call for the same concern. Our Longevity pillar covers the full range of modifiable risk factors to watch after age 50.
The link between joint inflammation and accelerated aging also connects to the data on chronic inflammation (inflammaging), of which osteoarthritis is one localized manifestation among others. On the cartilage itself, our article on collagen and joint health usefully complements this picture for anyone looking for nutritional levers.
| Profile | Risk measured | Magnitude | Reference study |
|---|---|---|---|
| Osteoarthritis (excluding hand), all locations | All-cause mortality | HR 1.18 (95% CI 1.08 to 1.28) | Veronese et al., 2016 |
| Isolated hand osteoarthritis | All-cause mortality | Not significantly increased | Veronese et al., 2016 |
| Radiographic knee osteoarthritis | Cardiovascular mortality | HR 1.43 (95% CI 1.32 to 1.64) | Mendy et al., 2018 |
| Radiographic knee osteoarthritis + diabetes + obesity | Diabetes-related mortality | HR 3.42 (95% CI 3.01 to 3.88) | Mendy et al., 2018 |
| Early-onset radiographic osteoarthritis (before age 40) | All-cause mortality | HR 1.53 (95% CI 1.43 to 1.65) | Mendy et al., 2018 |
Protocol: acting on the link between osteoarthritis and longevity
Movement remains the best documented measure, even in the presence of joint pain: appropriately adapted physical activity reduces inactivity, protects the remaining cartilage and acts directly on the cardiometabolic comorbidities linked to osteoarthritis. Our article on walking speed and longevity explains how to track this marker over time.
- Adapted physical activity: walking, swimming, cycling or water aerobics, aiming for 150 minutes a week of moderate intensity, while avoiding sports with repeated high impact on the joints.
- Targeted muscle strengthening: the quadriceps for the knee, the pelvic muscles for the hip, to reduce the mechanical strain on the cartilage.
- Weight control: every kilogram (2.2 lb) lost reduces the mechanical load on the knee by about four kilograms (8.8 lb) with each step, a factor that protects both the joints and cardiometabolic health.
- Regular cardiometabolic monitoring: lipid panel, blood glucose and blood pressure, particularly in people with osteoarthritis who are overweight or have limited mobility.
None of these levers reverses cartilage damage that has already occurred, but each one acts on the mechanisms that concretely link osteoarthritis to longevity: inactivity, inflammation and cardiometabolic load.
Frequently asked questions
Does osteoarthritis directly reduce life expectancy?
No, not directly. Large cohorts find no excess mortality linked to osteoarthritis overall. The risk rises mainly for certain forms, such as radiographic knee osteoarthritis, through the inactivity, chronic inflammation and cardiometabolic comorbidities it promotes.
Why is knee osteoarthritis riskier than hand osteoarthritis?
Knee osteoarthritis limits walking and daily physical activity more than hand osteoarthritis does, which promotes inactivity and cardiometabolic comorbidities. Available cohorts have found no link between isolated hand osteoarthritis and mortality.
Is osteoarthritis linked to inflammaging?
Yes, in part. Damaged cartilage releases inflammatory mediators that sustain chronic low-grade inflammation, a mechanism close to the inflammaging seen in overall body aging, though not entirely identical to it.
How can the impact of osteoarthritis on longevity be limited day to day?
Adapted physical activity, targeted muscle strengthening and weight control are the three best documented levers. They act on the mechanisms that link osteoarthritis to mortality, without claiming to repair cartilage that is already damaged.
Should you see a doctor for knee or hip osteoarthritis?
Yes, especially in the presence of excess weight, diabetes or a marked limitation in mobility. Regular cardiometabolic monitoring helps identify related comorbidities early and reduce the risk of long-term complications.
Medical disclaimer. The information provided here is for informational purposes only and does not constitute medical advice. It does not replace a consultation. Ask a healthcare professional before changing your diet, taking dietary supplements or starting a new practice, especially if you have a medical condition, are pregnant or are under treatment. Dietary supplements do not replace a balanced diet or medical follow-up.
